Physician profile

Robert W Priem

Family Medicine · Devon, PA

NPI 1598870909

$4,046.75

in general payments reported to CMS, 2019-2025

36 companies · $1,083 in 2025

The $1,083 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,051.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $521.91 2022-2025
Lilly USA, LLC $450.82 2022-2025 Jardiance, Mounjaro, Zepbound
Astrazeneca Pharmaceuticals LP $329.32 2019-2025 Breztri, Farxiga, Airsupra
Glaxosmithkline, LLC. $311.54 2022-2025 Trelegy Ellipta, Shingrix, Bexsero
Novo Nordisk INC $266.85 2019-2025 Rybelsus, Ozempic, Wegovy
Pfizer INC. $256.17 2019-2025
Boehringer Ingelheim Pharmaceuticals, INC. $240.56 2019-2025 Jardiance
Amarin Pharma, INC. $139.05 2019-2022
Merck Sharp & Dohme LLC $131.19 2019-2025 Gardasil 9, Capvaxive, Gardasil
Abbott Laboratories $119.44 2022-2025 Freestyle Libre 3, Freestyle Libre 2
Corium, LLC $115.45 2022-2024 Azstarys
Bausch Health US, LLC $111.97 2019-2024 Aplenzin, Wellbutrin
Teva Pharmaceuticals USA, INC. $104.94 2023-2025 Austedo Xr, Austedo, Austedo Xr
Amgen INC. $95.91 2019-2023 Otezla, Repatha
Astellas Pharma US INC $92.18 2023-2025 Veozah
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Seqirus USA INC $86.26 2022-2025 Flucelvax, Fluad
Exact Sciences Corporation $77.03 2023-2025 Cologuard Collection Kit
Neurocrine Biosciences, INC. $69.89 2025
Sanofi-Aventis U.S. LLC $67.56 2023-2025
Biofire Diagnostics, LLC $49.39 2019-2020
Biohaven Pharmaceutical Holding Company LTD. $47.69 2022
Sanofi Pasteur INC. $46.91 2023
Janssen Pharmaceuticals, INC $44.55 2019
Otsuka America Pharmaceutical, INC. $37.06 2025 Rexulti
Dexcom, INC. $32.24 2025 Dexcom G6 Transmitter
Ucb, INC. $24.44 2025 Nayzilam
Boston Scientific Corporation $23.32 2025 Wavewriter Alpha Prime 16
Novartis Pharmaceuticals Corporation $23.03 2022
Shield Therapeutics INC $19.90 2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $19.46 2022
Almatica Pharma LLC $17.04 2023 Gralise
Takeda Pharmaceuticals U.S.A., INC. $15.62 2020
Idorsia Pharmaceuticals US INC $15.35 2024 Quviviq
Kowa Pharmaceuticals America, INC. $15.34 2025 Zoryve
Philips North America LLC $15.29 2024 (Ak6) Vest Therapy
Supernus Pharmaceuticals, INC. $12.08 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert W Priem

$4,046.75

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,083 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/163560/robert-w-priem

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.